Bio:
Dr. Shicheng Guo, the current Director of Translational Genetics at Arrowhead Pharmaceuticals, boasts a distinguished career with significant roles at premier institutions. Previously, he served as a Principal Scientist at Johnson & Johnson’s Central Data Science Department. His academic tenure includes significant contributions at the University of Texas Health Science Center at Houston, the University of California, San Diego, and the University of Wisconsin-Madison, where he focused on advanced research in genetics and pharmacology. Dr. Guo, who earned his Ph.D. from Fudan University, has spearheaded pioneering projects in gene and RNA therapy, authored over 100 publications, and has been honored with numerous awards for his contributions to the field.
CABS Services and Awards
In addition to his scientific contributions, Dr. Guo has been dedicated to the CABS as a volunteer in 2022, EC member in O2 & BCD in 2023 and co-chair of O2 in 2024. He has contributed to maintaining the CABS, CABS-BioPacific, and CABS-Job websites, managing the CABS email and Google Drive systems, and initiating the CABS Data Science Summer Intern Program. Furthermore, Dr. Guo has been an active member of the organizing committees for the 2023 and 2024 CABS Biopacific conferences. His contributions to CABS were recognized with the 2023 “Special Contribution” and “Co-Chairs’ Picks” awards.
Visions, Goals, and Plans
- Empower and Innovation
- Empower Chair and EC to lead with innovation, equipping team to propose novel initiatives.
- Provide team training in AI-driven project management and automation strategies.
- Pioneering Community & Global Reach
- Position CABS as a global leader in biopharmaceutical innovation, expanding its role in global health.
- Enhance CABS’s influence within the Bay Area and across the Pacific Rim, including CA, OR and WA.
- Strategic Growth & Collaboration
- Enhance and diversify funding sources, including sponsorships and major industry donations.
- Expand partnerships with nonprofits, academic institutions and enhance interdisciplinary collaboration.
- Professional Development & Influence
- Boost CABS’s visibility in biopharma through active media engagement and strategic partnership
- Offer specialized training, certification programs, scholarships and internship program within the community.